S&P 500   3,300.06 (-2.67%)
DOW   26,713.68 (-2.73%)
QQQ   273.65 (-3.19%)
AAPL   112.77 (-3.28%)
MSFT   204.81 (-3.96%)
FB   269.66 (-4.81%)
GOOGL   1,521.66 (-4.83%)
AMZN   3,183.67 (-3.12%)
TSLA   409.60 (-3.55%)
NVDA   509.88 (-4.85%)
BABA   308.14 (-2.84%)
CGC   18.51 (-0.80%)
GE   7.52 (+5.92%)
MU   50.32 (-3.16%)
AMD   76.70 (-2.76%)
T   26.60 (-1.19%)
F   7.70 (-2.78%)
ACB   3.84 (-4.00%)
GILD   58.91 (-1.83%)
NFLX   489.63 (+0.14%)
NIO   27.61 (-2.92%)
BA   149.62 (-3.62%)
DIS   119.53 (-3.07%)
S&P 500   3,300.06 (-2.67%)
DOW   26,713.68 (-2.73%)
QQQ   273.65 (-3.19%)
AAPL   112.77 (-3.28%)
MSFT   204.81 (-3.96%)
FB   269.66 (-4.81%)
GOOGL   1,521.66 (-4.83%)
AMZN   3,183.67 (-3.12%)
TSLA   409.60 (-3.55%)
NVDA   509.88 (-4.85%)
BABA   308.14 (-2.84%)
CGC   18.51 (-0.80%)
GE   7.52 (+5.92%)
MU   50.32 (-3.16%)
AMD   76.70 (-2.76%)
T   26.60 (-1.19%)
F   7.70 (-2.78%)
ACB   3.84 (-4.00%)
GILD   58.91 (-1.83%)
NFLX   489.63 (+0.14%)
NIO   27.61 (-2.92%)
BA   149.62 (-3.62%)
DIS   119.53 (-3.07%)
S&P 500   3,300.06 (-2.67%)
DOW   26,713.68 (-2.73%)
QQQ   273.65 (-3.19%)
AAPL   112.77 (-3.28%)
MSFT   204.81 (-3.96%)
FB   269.66 (-4.81%)
GOOGL   1,521.66 (-4.83%)
AMZN   3,183.67 (-3.12%)
TSLA   409.60 (-3.55%)
NVDA   509.88 (-4.85%)
BABA   308.14 (-2.84%)
CGC   18.51 (-0.80%)
GE   7.52 (+5.92%)
MU   50.32 (-3.16%)
AMD   76.70 (-2.76%)
T   26.60 (-1.19%)
F   7.70 (-2.78%)
ACB   3.84 (-4.00%)
GILD   58.91 (-1.83%)
NFLX   489.63 (+0.14%)
NIO   27.61 (-2.92%)
BA   149.62 (-3.62%)
DIS   119.53 (-3.07%)
S&P 500   3,300.06 (-2.67%)
DOW   26,713.68 (-2.73%)
QQQ   273.65 (-3.19%)
AAPL   112.77 (-3.28%)
MSFT   204.81 (-3.96%)
FB   269.66 (-4.81%)
GOOGL   1,521.66 (-4.83%)
AMZN   3,183.67 (-3.12%)
TSLA   409.60 (-3.55%)
NVDA   509.88 (-4.85%)
BABA   308.14 (-2.84%)
CGC   18.51 (-0.80%)
GE   7.52 (+5.92%)
MU   50.32 (-3.16%)
AMD   76.70 (-2.76%)
T   26.60 (-1.19%)
F   7.70 (-2.78%)
ACB   3.84 (-4.00%)
GILD   58.91 (-1.83%)
NFLX   489.63 (+0.14%)
NIO   27.61 (-2.92%)
BA   149.62 (-3.62%)
DIS   119.53 (-3.07%)
Log in
NASDAQ:HSKA

Heska Stock Forecast, Price & News

$112.12
-0.13 (-0.12 %)
(As of 10/28/2020 03:14 PM ET)
Add
Compare
Today's Range
$109.78
Now: $112.12
$112.89
50-Day Range
$94.99
MA: $102.40
$120.78
52-Week Range
$50.00
Now: $112.12
$122.19
Volume1,335 shs
Average Volume68,384 shs
Market Capitalization$1.06 billion
P/E RatioN/A
Dividend YieldN/A
Beta1.68
Heska Corporation manufactures, sells, and markets veterinary diagnostic and specialty products for canine and feline healthcare markets in the United States, Canada, Europe, and internationally. The company's Core Companion Animal segment offers Element DC and DRI-CHEM 7000 veterinary chemistry analyzers for blood chemistry and electrolyte analysis; Element HT5 and HemaTrue veterinary hematology analyzers to measure blood cell and platelet count, and hemoglobin levels; Element POC blood gas and electrolyte analyzers; Element i immunodiagnostic analyzers; Element COAG veterinary analyzers; and IV infusion pumps. It also provides digital radiography hardware and mobile digital radiography products, as well as ultrasound systems; Cloudbank, a Web-based image storage solution; ViewCloud, a picture archival and communications system for Cloudbank; point-of-care heartworm diagnostic test products for dogs and cats; Tri-Heart Plus chewable tablets for the treatment of canine heartworm infection, and treatment and control of ascarid and hookworm infections; and allergy products and services, including ALLERCEPT definitive allergen panels, and therapy shots or drops. The company's Other Vaccines and Pharmaceuticals segment offers a line of bovine vaccines; biological and pharmaceutical products for other animal health companies; and various turnkey services comprising research, licensing, production, labeling, and packaging, as well as provides validation support and distribution services. Heska Corporation sells its products to veterinarians through a field organization, a telephone sales force, and third party distributors; and trade shows, print advertising, and other distribution relationships. The company was formerly known as Paravax, Inc. and changed its name to Heska Corporation in 1995. Heska Corporation was founded in 1988 and is headquartered in Loveland, Colorado.
Read More
Heska logo

Beat the Market (BTM) Rank

Analyst Opinion: 1.4Community Rank: 2.4Dividend Strength: 0.0Insider Behavior: 1.0Valuation: 0.6 5 -4 -3 -2 -1 -

Overall Beat the Market Rank

1.09 out of 5 stars

Industry, Sector and Symbol

Industry Diagnostic substances
Sub-IndustryN/A
SectorMedical
Current SymbolNASDAQ:HSKA
CUSIPN/A
Phone970-493-7272
Employees347

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$122.66 million
Cash Flow$0.99 per share
Book Value$19.72 per share

Profitability

Net Income$-1,470,000.00

Miscellaneous

Market Cap$1.06 billion
Next Earnings Date11/5/2020 (Confirmed)
OptionableNot Optionable
$112.12
-0.13 (-0.12 %)
(As of 10/28/2020 03:14 PM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive HSKA News and Ratings via Email

Sign-up to receive the latest news and ratings for HSKA and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles











Heska (NASDAQ:HSKA) Frequently Asked Questions

How has Heska's stock price been impacted by COVID-19?

Heska's stock was trading at $81.83 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization (WHO). Since then, HSKA stock has increased by 35.0% and is now trading at $110.50.
View which stocks have been most impacted by COVID-19
.

Do Wall Street analysts recommend investors buy shares of Heska?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Heska in the last year. There are currently 1 hold rating and 4 buy ratings for the stock, resulting in a consensus recommendation of "Buy."
View analyst ratings for Heska
.

When is Heska's next earnings date?

Heska is scheduled to release its next quarterly earnings announcement on Thursday, November 5th 2020.
View our earnings forecast for Heska
.

How can I listen to Heska's earnings call?

Heska will be holding an earnings conference call on Thursday, November 5th at 12:00 AM Eastern. Interested parties can register for or listen to the call using this link or dial in at Not Available.

How were Heska's earnings last quarter?

Heska Corp (NASDAQ:HSKA) announced its quarterly earnings results on Tuesday, August, 4th. The medical research company reported ($0.72) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.43) by $0.29. The medical research company had revenue of $45.71 million for the quarter, compared to the consensus estimate of $41.94 million. Heska had a negative return on equity of 1.57% and a negative net margin of 9.57%.
View Heska's earnings history
.

What guidance has Heska issued on next quarter's earnings?

Heska updated its FY 2020 Pre-Market earnings guidance on Tuesday, August, 4th. The company provided earnings per share guidance of for the period. The company issued revenue guidance of $175-185 million, compared to the consensus revenue estimate of $175.66 million.

What price target have analysts set for HSKA?

5 analysts have issued 1-year price targets for Heska's shares. Their forecasts range from $59.00 to $125.00. On average, they expect Heska's stock price to reach $103.10 in the next year. This suggests that the stock has a possible downside of 6.7%.
View analysts' price targets for Heska
.

Who are some of Heska's key competitors?

What other stocks do shareholders of Heska own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Heska investors own include Gilead Sciences (GILD), Exxon Mobil (XOM), Netflix (NFLX), Biogen (BIIB), AbbVie (ABBV), Amgen (AMGN), Broadcom (AVGO), Alibaba Group (BABA), Exelixis (EXEL) and Merck & Co., Inc. (MRK).

Who are Heska's key executives?

Heska's management team includes the following people:
  • Mr. Kevin S. Wilson, CEO, Pres & Director (Age 47)
  • Mr. Jason A. Napolitano, COO & Chief Strategist (Age 51)
  • Ms. Catherine I. Grassman CPA, VP, Chief Accounting Officer & Corp. Controller (Age 43)
  • Dr. Nancy Wisnewski, Exec. VP of Diagnostic Operations & Product Devel. (Age 56)
  • Mr. Jason D. Aroesty, Exec. VP of International Diagnostics (Age 44)

What is Heska's stock symbol?

Heska trades on the NASDAQ under the ticker symbol "HSKA."

Who are Heska's major shareholders?

Heska's stock is owned by many different retail and institutional investors. Top institutional investors include Standard Life Aberdeen plc (3.53%), Riverbridge Partners LLC (2.88%), Grace & White Inc. NY (0.31%), State of New Jersey Common Pension Fund D (0.23%), KBC Group NV (0.10%) and State of Alaska Department of Revenue (0.09%). Company insiders that own Heska stock include G Irwin Gordon, Jason A Napolitano, Kevin S Wilson, Nancy Wisnewski and Scott Humphrey.
View institutional ownership trends for Heska
.

Which institutional investors are selling Heska stock?

HSKA stock was sold by a variety of institutional investors in the last quarter, including Riverbridge Partners LLC, Grace & White Inc. NY, and State of New Jersey Common Pension Fund D. Company insiders that have sold Heska company stock in the last year include Kevin S Wilson, and Nancy Wisnewski.
View insider buying and selling activity for Heska
.

Which institutional investors are buying Heska stock?

HSKA stock was acquired by a variety of institutional investors in the last quarter, including Standard Life Aberdeen plc, KBC Group NV, Louisiana State Employees Retirement System, Envestnet Asset Management Inc., and State of Alaska Department of Revenue.
View insider buying and selling activity for Heska
.

How do I buy shares of Heska?

Shares of HSKA can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.

What is Heska's stock price today?

One share of HSKA stock can currently be purchased for approximately $110.50.

How big of a company is Heska?

Heska has a market capitalization of $1.04 billion and generates $122.66 million in revenue each year. The medical research company earns $-1,470,000.00 in net income (profit) each year or $0.05 on an earnings per share basis. Heska employs 347 workers across the globe.

What is Heska's official website?

The official website for Heska is www.heska.com.

How can I contact Heska?

Heska's mailing address is 3760 ROCKY MOUNTAIN AVENUE, LOVELAND CO, 80538. The medical research company can be reached via phone at 970-493-7272 or via email at [email protected]

This page was last updated on 10/28/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.